12.01
-0.36 (-2.91%)
| Penutupan Terdahulu | 12.37 |
| Jumlah Dagangan | 1,469,433 |
| Harga / Jualan (P/S) | 7.45 |
| Harga / Buku (P/B) | 2.12 |
| Julat 52 Minggu |
| Margin Keuntungan | -198.84% |
| Margin Operasi (TTM) | -182.09% |
| EPS Cair (TTM) | -8.91 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 27.30% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 67.12% |
| Nisbah Semasa (MRQ) | 4.88 |
| Aliran Tunai Operasi (OCF TTM) | -281.85 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -185.65 M |
| Pulangan Atas Aset (ROA TTM) | -16.99% |
| Pulangan Atas Ekuiti (ROE TTM) | -57.76% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Ginkgo Bioworks Holdings, Inc. | Bercampur | Menurun |
AISkor Stockmoo
| Nilai 35% | -0.7 |
| AI Insight info | NA |
| Penilaian Relatif info | NA |
| Kesihatan Kewangan info | -0.7 |
| Masa 35% | 0.3 |
| AI Technical info | NA |
| Osilator Teknikal info | 0.5 |
| Purata Bergerak Teknikal info | 0.0 |
| Wang Pintar 30% | 0.0 |
| Konsensus Penganalisis info | 0.0 |
| Aktiviti Orang Dalam info | NA |
| Persekitaran | ×1.21 |
| Persekitaran Makro info | -3.3 |
| Sektor berbanding Pasaran (6B) | -22.4% |
| Persetujuan Tonggak | ×0.95 |
| Tidak dikira dalam skor | |
| Volatiliti Harga info | -5.0 |
| Skor Akhir | -0.16 |
|
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 6.88% |
| % Dimiliki oleh Institusi | 77.96% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Erste Asset Management Gmbh | 30 Jun 2026 | 2,536,939 |
| Anchorage Capital Group, L.L.C. | 30 Jun 2026 | 1,746,363 |
| Forbes J M & Co Llp | 30 Sep 2026 | 977,371 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |